Earnings Preview: Allergan
April 29, 2010
Allergan (AGN) is expected to report Q1 earnings Friday, April 30 before the market open, with a conference call scheduled for 9 am ET.
Guidance
Analysts are looking for EPS of 60c on revenue of 1.11B. The consensus range is 58c-66c for EPS, and $1.07B-$1.18B for revenue, according to First Call. In early February the company gave Q1 EPS guidance of 57c-59c. At the time the EPS consensus estimate for Q1 was 68c. Botox sales may have strengthened as a result of the economic recovery and a rebound in discretionary consumer spending. Another positive for Q1 is seen coming from Latisse, a drug that has been found to enhance eyelash growth. Ophthalmic drugs should also be a positive driver for Allergan in Q1. Possible negative pressures this quarter may be seen coming from Dysport competing for Botox sales.
Analyst Views
On April 19, Goldman Sachs upgraded Allergan to Conviction Buy from Neutral.
Source: http://seekingalpha.com/article/201757-earnings-preview-allergan
Differentiation: The key to generating more business in a soft market
April 23, 2010
The economy has the cosmetic plastic surgery business sagging and in need of a real lift.
The American Society for Aesthetic Plastic Surgery (ASAPS) recently released some concerning statistics about the cosmetic plastic surgery business. In 2009, according to ASAPS, spending on plastic surgery services fell 20 percent to $10.5 billion. Further, the number of cosmetic surgical procedures dropped by 17 percent to 1.47 million.
Certainly the worst economy since the Great Depression played a major role in the decrease. Unfortunately, it’s likely to remain as such at least through the next several quarters. Aesthetic medicine practices of all sizes now must work even harder in a competitive industry to win their piece of a diminishing – at least for the time being – market. Read more
Merz to complete acquisition of BioForm Medical
February 23, 2010
Merz Pharma Group has reported that the subsequent offering period of the tender offer by Merz GmbH & Co and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical at a price of $5.45 per share, net to the seller in cash expired as scheduled on February 18, 2010.
Based on final information from the depositary for the tender offer, 45.4 million shares, representing approximately 95.7% of the outstanding shares of common stock of BioForm Medical, were validly tendered and not withdrawn prior to the expiration of the subsequent offering period. All such shares have been accepted for payment in accordance with the terms of the tender offer, and Merz has or will promptly pay for all such shares. Read more
Aesthetic Accreditation Agency Established
December 15, 2008
Recently in California, medical spas have been the target of legislation intended to regulate the medical spa industry. Aesthetic Accreditation Agency was established in 2008 due to new legislative changes that seek to improve patient safety and the standard of care in the medical spa setting. While hospitals and surgery centers have been accredited by several organizations for decades, the aesthetic facility environment has not had a dedicated accreditation program that examines all aspects of patient safety and quality care. Aesthetic Accreditation Agency is an accrediting and consulting program which will continually monitor and implement advances in aesthetic quality patient care. This requires constant review and revision of standards to reflect the latest changes and developments. We are at the forefront of legislative efforts to provide patients with safety and quality assurance in the medical spa setting. Read more
California Bill could Put non-Physician Owned MedSpas out of Business
April 16, 2008
URGENT UPDATE (4-16-08) AB 2398 COSMETIC REGULATION
(Submitted by Norman C. Davis, Esq.)
The Business & Professions Committee of the State Assembly held a bill hearing on April 9, 2008 at which time the proposed AB 2398 (Amended April 1, 2008) was presented to the Committee. Unfortunately, following a brief discussion and only a few minor changes made, the bill was approved by the Committee.
An amended draft of the bill was drafted on 4-10-08 and was approved by the Assembly Judiciary Committee on April 15th. The bill will now go to the full Assembly where it must be approved prior to May 31, 2008 in order to be sent to the Senate or it will die. Refer to the current attached draft.
This legislation is sponsored by the American Society for Dermatologic Surgery, and if passed will have a monumental impact on physicians, nurses, NPs , PAs and management companies involved in the aesthetic field. Physicians who are involved in aesthetic practices on a part-time basis must be on-site, providing direct supervision of delegated procedures, and must personally provide good faith exams on all patients prior to delegation. RNs will not be allowed to perform any procedures without the physician on-site unless the treatment is performed in a physician owned office with certain restrictions. Read more
Adding cosmetic procedures lifts internists sagging incomes
April 8, 2008
A few years ago, Bill J. Johnson, ACP Member, was spending most of his day treating patients for hypertension, diabetes and other chronic ailments. But while he enjoyed his work, his income had stagnated amid tightening insurance reimbursements. That’s when he began to think about adding aesthetic procedures to his menu of services.
Dr. Johnson took the leap in 2005, starting by offering botulinum toxin injections and then dermal filler injections at his office in Grapevine,
Key Legal Issues for Medical Spas and Aesthetic Medical Practices
March 19, 2008
Key Legal Issues for Medical Spas and Aesthetic Medical Practices
Aesthetic medicine requires careful attention to the intersection of corporate practice of medicine, licensing, anti-kickback and fee-splitting considerations, and other legal and regulatory issues. This overview will help you better understand the legal implications of opening a medical spa.
Understanding Staff Needs
March 11, 2008
The staff you employ can make or break your practice – period. When aesthetic patients are using their own money for elective procedures, their experience with you (and your staff) needs to be a good one – every single time. Because if it’s not, they will go where they are treated better and they’ll take their friends with them.
Frankly, your staff’s patient relations skills are just as important as your aesthetic skills when it comes to growing your aesthetic practice. Read more
United States: Botox® At the Mall? A Look At Medical Spas Under California Law
March 1, 2008
Medical Spas seem to be popping up all over these days. More and more Southern Californians, both men and women, view a Botox ® injection or laser hair reduction as a cosmetic treatment rather than as a medical procedure. Likewise, people are willing to obtain these services in the same settings they use for pedicures—in day spas or even in mall stores. Frequently, the operators of these medical spas are no more aware of the legal requirements that apply to their businesses than are their customers, as both the providers and consumers of the services see these services as esthetic in nature. But because California law defines many of the services that medical spas provide as the practice of medicine, there are numerous traps for the unwary spa operator. Read more
How to Win Back Patients you’ve Lost
February 14, 2008
You may be sitting on a gold mine and don’t even know it. I guarantee you have long-long patients in your practice who would return to you if given a chance.
If you have been in practice for even a short time, you have developed an eclectic database of various types of patients who:
- currently visit you
- who used to visit you but now don’t
- who are angry at you and you don’t even know it
- who talk badly about you
- who would come back if you only apologized
Your database is filled with patients who took the time to call your office, set up an appointment and visit you. For whatever reason, they didn’t book a consultation, didn’t return to finish their appointments or have left your office never to return again.
Aesthetic patients are fickle consumers. Rather than a goldmine, it can be more like a mine field to understand these patients and why they chose you over all the others. Read more










